Discrimination between benign and malignant melanocytic skin lesions by multivariate analysis, quantitative S-100 immunohistochemistry, nuclear morphometry and DNA cytometry

Analytical and Quantitative Cytology and Histology

Volumn 21, Issue 4, 1999, Pages 353-357

  Williams, Richard A ^a   Rode, Jurgen ^a   Baak, Jan P A ^b   Charlton, Ian G ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA CONTENT; HISTOGRAM; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; MELANOCYTIC NEVUS; MELANOMA; MULTIVARIATE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMAGE CYTOMETRY; IMAGE PROCESSING, COMPUTER-ASSISTED; KARYOMETRY; MELANOMA; MULTIVARIATE ANALYSIS; PLOIDIES; S100 PROTEINS; SKIN NEOPLASMS;

EID: 0032817061     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Auer GU: Image cytometric nuclear DNA analysis in clinical tumour material. In Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Edited by JPA Baak. Berlin, Springer-Verlag, 1991, pp 217-218
2. Bergman W, Ruiter DJ, Scheffer E, van Vloten WA: Melanocytic atypia in dysplastic nevi: Immunohistochemical and cytophotometrical analysis. Cancer 1988;61:1660-1666
3. Cochran AJ, Wen D-R: S-100 protein as a marker for melanocytic and other tumors. Pathology 1985;17:340-345
4. Dhillon AP, Rode J: Immunohistochemical studies of S100 protein and other neural characteristics expressed by granular cell tumor. Diagn Histopathol 1983;6:23-28
5. Elder DE, Murphy GF: Melanocytic tumours of the skin. In Atlas of Tumor Pathology. Third series, fascicle 2. Washington, DC, Armed Forces Institute of Pathology, 1991
6. Fand SB: Environmental conditions for optimal Feulgen hydrolysis. In Introduction to Quantitative Cytochemistry. Edited by GL Wied, GF Bahr. New York, Academic Press, 1970, pp 209-222
7. Gaynor R, Hershman HR, Irie R, Jones P, Mortan D, Cochran AJ: S-100 protein: A marker for human malignant melanoma? Lancet 1981;1:869-871
8. Hagen EC, Vennegoor C, Schlingemann RO, van der Velde EA, Ruiter DJ: Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections. Histopathology 1986;10:689-700
9. Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y, Ishihara K: Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 1982;50:912-918
10. Pehamberger H, Binder M, Steiner A, Wolff K: Early recognition and prognostic markers of melanoma. Melanoma Res 1993;3:279-284
11. Rode J, Dhillon AP: Neurone specific enolase and S100 protein as possible prognostic indicators in melanoma. Histopathology 1984;8:1041-1052
12. Springall DR, Gu J, Cocchia D, Michetti F, Levene A, Levene MM, Marangos PJ, Bloom SR, Polak JM: The value of S100 immunostaining as a diagnostic tool in human malignant melanomas. Virchows Arch 1983;400:331-343
13. Tan GJKH, Baak JPA: Evaluation of prognostic characteristics of stage 1 cutaneous malignant melanoma. Analyt Quant Cytol Histol 1984;6:147-154
14. Williams RA, Rode J, Dhillon AP, Jarvis LR, Skinner JM, Jamal O: Measuring S100 protein and neurone specific enolase in melanocytic tumors using video image analysis. J Clin Pathol 1986;39:1096-1098